On March 10, 2023, Shenzhen MGI Tech Co.,Ltd. and Yeasen Biotechnology (Shanghai) Co., Ltd. officially reached a strategic cooperation to promote the localization of high-throughput sequencing (NGS) reagents and instruments in China.

Japanese healthcare firm Sysmex said that it has signed a global supply agreement for hemostasis instruments and reagents with Siemens Healthineers.​

Roche Diagnostics plans to bring a fully automated mass spectrometry-based clinical analyzer to market in 2024.

Sysmex said this week it had received manufacturing and marketing approval in Japan for a pair of assay kits to identify elevated amyloid beta concentrations characteristic of Alzheimer's disease.

French diagnostics maker BioMérieux said on Tuesday that it has received CE marking for its Vidas Kube automated immunoassay system.

Roche announced on Tuesday that it is launching three new tests on its molecular Cobas 5800 instrument in countries accepting the CE mark.

Roche announced on Monday that its Cobas Pure Integrated Solutions instrument has received 510(k) clearance from the US Food and Drug Administration.

Qiagen announced on Thursday that it has obtained the CE-IVD mark for RT-PCR assays to detect and quantify Epstein-Barr virus and human herpesvirus-6 on its NeuMoDx instruments.

Expects Q4 2021 revenue of $29-31 million; Full year 2021 revenue of $109-111 million

Becton Dickinson announced on Friday that it has received the CE-IVD mark for a new instrument component of its BD Cor system.